(Q73871064)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Leishmania donovani

1 reference

A Misra

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Dube

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

B Srivastava

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Sharma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J K Srivastava

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J C Katiyar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Naik

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

25-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

3485-3492

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

Experiences with vaccines against cutaneous leishmaniasis: of men and mice

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Phytohaemagglutinin-induced lymphocyte transformation test in Indian kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Characterization of in Vitro Proliferative Responses of Human Lymphocytes to Leishmanial Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Circulating factor from a kala-azar patient suppresses in vitro antileishmanial T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Cutaneous leishmaniasis: The prospects for a killed vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Vaccines against leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Stepwise safety trial of a killed Leishmania vaccine in Iran

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Vaccine for prophylaxis and immunotherapy, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Comparative safety and immunogenicity trial of two killed Leishmania Major vaccines with or without BCG in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Leishmania donovani: cellular and humoral immune responses in Indian langur monkeys, Presbytis entellus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Natural and experimental re-infection of man with Oriental sore

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Follow-up study of a vaccination programme against cutaneous leishmaniasis. II. Vaccination with a recently isolated strain of L. tropica from Jericho

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900058-5

7 January 2021

10.1016/S0264-410X(01)00058-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11348715%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference